科兴制药(688136.SH)发布上半年业绩，归母净利润8034.45万元，同比增长576.45%

Core Insights - The company reported a revenue of 700 million yuan for the first half of 2025, representing a year-on-year decrease of 7.82% [1] - The net profit attributable to shareholders reached 80.34 million yuan, showing a significant year-on-year increase of 576.45% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 45.28 million yuan, reflecting a year-on-year growth of 110.30% [1] - The basic earnings per share stood at 0.41 yuan [1]